<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02488187</url>
  </required_header>
  <id_info>
    <org_study_id>ABUS</org_study_id>
    <nct_id>NCT02488187</nct_id>
  </id_info>
  <brief_title>Comparison of Preoperative ABUS and MRI in Newly Diagnosed Breast Cancer Patients</brief_title>
  <acronym>ABUS</acronym>
  <official_title>Comparison of Preoperative Automated Breast Ultrasound (ABUS) and Magnetic Resonance Imaging (MRI) in Newly Diagnosed Breast Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Kansas Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kansas Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of Preoperative Automated Breast Ultrasound (ABUS) and magnetic resonance imaging&#xD;
      (MRI) in Newly Diagnosed Breast Cancer Patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective pilot study investigating the use of Automated Breast Ultrasound in the&#xD;
      preoperative evaluation of newly diagnosed breast cancer patients. The Investigator intends&#xD;
      to demonstrate that preoperative automated breast ultrasound (ABUS) will provide a relatively&#xD;
      inexpensive and well-tolerated alternative to MRI for detection of occult breast cancer&#xD;
      missed by mammography and hand-held ultrasound in women with newly diagnosed breast cancer.&#xD;
      The research will take place at the University of Kansas Medical Center (KUMC). The research&#xD;
      study will be open to newly diagnosed breast cancer patients who present to KUMC with a&#xD;
      recommendation for preoperative MRI and who fit all inclusion criteria and have none of the&#xD;
      exclusion criteria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measure rate of detection of occult breast cancer by ABUS that was not detected by standard imaging</measure>
    <time_frame>1 day</time_frame>
    <description>Rate of detection of occult breast cancer by ABUS, otherwise missed by standard imaging (MRI or mammogram with hand-held breast ultrasound as clinically indicated).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">115</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>ABUS vs MRI (ultrasound when indicated)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>To compare the overall sensitivity and specificity of ABUS versus MRI (and hand-held breast ultrasound when clinically indicated) for the ipsilateral and contralateral breast in newly diagnosed breast cancer patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ABUS vs mammography (ultrasound when indicated)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>To compare the sensitivity and specificity of ABUS versus mammography (and hand-held breast ultrasound when clinically indicated) for the ipsilateral and contralateral breast in newly diagnosed breast cancer patients when MRI is not performed.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ABUS</intervention_name>
    <description>Automated breast ultrasound</description>
    <arm_group_label>ABUS vs MRI (ultrasound when indicated)</arm_group_label>
    <arm_group_label>ABUS vs mammography (ultrasound when indicated)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women (age 18-100) undergoing preoperative evaluation at the University of Kansas&#xD;
             Cancer Center (KUCC) for a new diagnosis of breast cancer&#xD;
&#xD;
          -  Patients with a diagnosis of breast cancer by either core needle biopsy or excisional&#xD;
             biopsy.&#xD;
&#xD;
          -  Bilateral mammography and hand-held ultrasound (if clinically indicated) performed&#xD;
             prior to the MRI and ABUS.&#xD;
&#xD;
          -  If a breast MRI is advised and there is no contraindication to MRI, a breast MRI and&#xD;
             ABUS will performed at KUCC (Study Arm 1).&#xD;
&#xD;
          -  If a breast MRI is not performed, an ABUS exam without MRI will be performed (Study&#xD;
             Arm 2).&#xD;
&#xD;
          -  The MRI and ABUS exam must be obtained within 2 weeks of each other.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Males&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Lactating women&#xD;
&#xD;
          -  Patients &lt; 18 and &gt; 100 years of age&#xD;
&#xD;
          -  Patients with breast implants&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Kansas Cancer Center</name>
      <address>
        <city>Westwood</city>
        <state>Kansas</state>
        <zip>66205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>June 30, 2015</study_first_submitted>
  <study_first_submitted_qc>June 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2015</study_first_posted>
  <last_update_submitted>January 18, 2017</last_update_submitted>
  <last_update_submitted_qc>January 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast Cancer</keyword>
  <keyword>MRI</keyword>
  <keyword>Mammogram</keyword>
  <keyword>Whole Breast Sonogram</keyword>
  <keyword>ABUS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>March 1, 2018</submitted>
    <returned>March 28, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

